APOA1 and amyotrophic lateral sclerosis: A specific focus was examining the inhibition of the PI3K/Akt signaling pathway and blockage of ApoA1 integration in damaged ECs in development of ApoA1 as a potential therapeutic agent for endothelium repair in ALS.